Abstract:Understanding how mucosal pathogens modulate the immune response may facilitate the development of vaccines for disparate human diseases. In the present study, human monocyte-derived DC (MDDC) were pulsed with LPS of the oral pathogen Porphyromonas gingivalis and Escherichia coli 25922 and analyzed for: (i) production of Th-biasing/inflammatory cytokines; (ii) maturation/costimulatory molecules; and (iii) induction of allogeneic CD4 + and naive CD45RA + T cell proliferation and release of Th1 or Th2 cytokines.… Show more
“…Moreover, preimmunization of BALB/c mice with P. gingivalis in the presence of IL-12 resulted in enhanced P. gingivalis-specific T cell proliferation, a strongly polarized Th1 immune response including IFN-␥ production, and the induction of severe periapical bone loss (43). Although P. gingivalis LPS has been reported to induce Th2 effector responses in dendritic cells (44), costimulation of dendritic cells with P. gingivalis LPS and IFN-␥ significantly enhanced both p35 and p40 IL-12 mRNA, while failing to up-regulate IL-10 mRNA (45). Thus, distinct patterns of polarization of the T cell response may be induced by P. gingivalis LPS compared with infection with the live organism.…”
Periodontal disease is a chronic inflammatory disease in the oral cavity, which culminates in alveolar bone loss. Porphyromonas gingivalis is a consensus periodontal pathogen that has been implicated in adult forms of periodontitis. We previously demonstrated that IL-10-deficient mice exhibit a hyperinflammatory phenotype and are highly susceptible to P. gingivalis-induced periodontitis, indicating an important anti-inflammatory effect of IL-10 in suppressing bone loss. In this study, we analyzed the pathway(s) by which IL-10 deficiency leads to severe P. gingivalis-induced periodontitis. Because Stat3 is essential in IL-10 signaling, immune cell-specific Stat3-deficient mice were subjected to P. gingivalis infection to identify the key IL-10-responsive cells in preventing periodontitis. Myeloid cell-specific Stat3-deficient mice exhibited increased periodontal bone loss (p < 0.001), whereas T cell- and B cell-specific Stat3 mice were resistant, suggesting that macrophages (MP) and/or polymorphonuclear leukocytes are the key target cells normally suppressed by IL-10. Myeloid cell-specific Stat3-deficient mice exhibited elevated gingival CD40L gene expression in vivo compared with wild-type controls (p < 0.01), and Stat3-deficient MPs exhibited vigorous P. gingivalis-stimulated IL-12 production in vitro and induced elevated Ag-specific T cell proliferation compared with wild-type MPs (p < 0.01). Of importance, both IL-12p40/IL-10 and T cell/IL-10 double-deficient mice were resistant to P. gingivalis-induced periodontitis, demonstrating roles for both IL-12p40 and T cells in pathogenesis in a hyperinflammatory model of disease. These data demonstrate that P. gingivalis-induced periodontitis in IL-10-deficient mice is dependent upon IL-12p40-mediated proinflammatory T cell responses.
“…Moreover, preimmunization of BALB/c mice with P. gingivalis in the presence of IL-12 resulted in enhanced P. gingivalis-specific T cell proliferation, a strongly polarized Th1 immune response including IFN-␥ production, and the induction of severe periapical bone loss (43). Although P. gingivalis LPS has been reported to induce Th2 effector responses in dendritic cells (44), costimulation of dendritic cells with P. gingivalis LPS and IFN-␥ significantly enhanced both p35 and p40 IL-12 mRNA, while failing to up-regulate IL-10 mRNA (45). Thus, distinct patterns of polarization of the T cell response may be induced by P. gingivalis LPS compared with infection with the live organism.…”
Periodontal disease is a chronic inflammatory disease in the oral cavity, which culminates in alveolar bone loss. Porphyromonas gingivalis is a consensus periodontal pathogen that has been implicated in adult forms of periodontitis. We previously demonstrated that IL-10-deficient mice exhibit a hyperinflammatory phenotype and are highly susceptible to P. gingivalis-induced periodontitis, indicating an important anti-inflammatory effect of IL-10 in suppressing bone loss. In this study, we analyzed the pathway(s) by which IL-10 deficiency leads to severe P. gingivalis-induced periodontitis. Because Stat3 is essential in IL-10 signaling, immune cell-specific Stat3-deficient mice were subjected to P. gingivalis infection to identify the key IL-10-responsive cells in preventing periodontitis. Myeloid cell-specific Stat3-deficient mice exhibited increased periodontal bone loss (p < 0.001), whereas T cell- and B cell-specific Stat3 mice were resistant, suggesting that macrophages (MP) and/or polymorphonuclear leukocytes are the key target cells normally suppressed by IL-10. Myeloid cell-specific Stat3-deficient mice exhibited elevated gingival CD40L gene expression in vivo compared with wild-type controls (p < 0.01), and Stat3-deficient MPs exhibited vigorous P. gingivalis-stimulated IL-12 production in vitro and induced elevated Ag-specific T cell proliferation compared with wild-type MPs (p < 0.01). Of importance, both IL-12p40/IL-10 and T cell/IL-10 double-deficient mice were resistant to P. gingivalis-induced periodontitis, demonstrating roles for both IL-12p40 and T cells in pathogenesis in a hyperinflammatory model of disease. These data demonstrate that P. gingivalis-induced periodontitis in IL-10-deficient mice is dependent upon IL-12p40-mediated proinflammatory T cell responses.
“…P. gingivalis also expresses unique immunosuppressive LPS (Cohen et al, 2004;Jotwani et al, 2003;Pulendran et al, 2001) and proteolytic gingipains (Potempa et al, 2003). LPS of P. gingivalis, relative to those of Escherichia coli, stimulate dendritic cells to secrete IL-10, but not IL-12, in vitro (Jotwani et al, 2003) and in vivo (Pulendran et al, 2001).…”
Section: Immune Evasion By Bacteriamentioning
confidence: 99%
“…P. gingivalis also expresses unique immunosuppressive LPS (Cohen et al, 2004;Jotwani et al, 2003;Pulendran et al, 2001) and proteolytic gingipains (Potempa et al, 2003). LPS of P. gingivalis, relative to those of Escherichia coli, stimulate dendritic cells to secrete IL-10, but not IL-12, in vitro (Jotwani et al, 2003) and in vivo (Pulendran et al, 2001). These two factors (sub-optimal DC maturation and truncated cytokine expression) leads to the induction of a Th2-effector response, which suggests that P. gingivalis may target dendritic cell C-type lectin receptors (e.g., dendritic cell-specific ICAM-3-grabbing non-integrins) for entry, and for blunting of dendritic cell maturation.…”
For more than two decades, Biotechnology and Bioengineering has documented research focused on natural and engineered microbial biofilms within aquatic and subterranean ecosystems, wastewater and waste-gas treatment systems, marine vessels and structures, and industrial bioprocesses. Compared to suspended culture systems, intentionally engineered biofilms are heterogeneous reaction systems that can increase reactor productivity, system stability, and provide inherent cell:product separation. Unwanted biofilms can create enormous increases in fluid frictional resistances, unacceptable reductions in heat transfer efficiency, product contamination, enhanced material deterioration, and accelerated corrosion. Missing from B&B has been an equivalent research dialogue regarding the basic molecular microbiology, immunology, and biotechnological aspects of medical biofilms. Presented here are the current problems related to medical biofilms; current concepts of biofilm formation, persistence, and interactions with the host immune system; and emerging technologies for controlling medical biofilms.
“…This exciting observation demonstrates a clear regulatory role for IL-19: the modulation of DC function. IL-10-rich DC are found in chronic inflammatory environments, such as the periodontal lesion [35][36][37]. These IL-10 + DC are thought to skew the T cell response towards the Th2 type.…”
Section: Il-19 Up-regulates Il-10 Production In Monocytederived DCmentioning
IL‐19 is a novel, recently identified member of the IL‐10 family of cytokines. We identified IL‐10 as a cytokine that was strongly induced in IL‐19‐stimulated PBMC. IL‐19‐induced IL‐10 secretion was dose‐dependent and could be detected in culture supernatants after 3 h of stimulation. Furthermore, quantitative RT‐PCR analysis demonstrated that IL‐19 stimulation increased the level of IL‐10 mRNA present within cells, suggesting that IL‐19 is a transcriptional activator of IL‐10. IL‐19 was also able to induce its own expression, with IL‐10 potently down‐regulating this IL‐19 ‘auto‐induction’. LPS induction of IL‐19 expression was also regulated by IL‐10, demonstrating that IL‐10 is likely an important regulator of human IL‐19 induction. Maturation of dendritic cells from human PBMC in the presence of IL‐19 resulted in an increase in IL‐10 levels within these cells, whereas IL‐12 was not affected. These results advance our understanding of the function of this novel cytokine and its regulation within the human immune system, in addition to providing a new insight into the control of the important immunoregulatory cytokine, IL‐10.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.